TGFB1 and endometrial cancer: Despite a small number of studies, so far, addressing the anti-invasive and/or anti-migratory effects of metformin in endometrial cancer cells, this study is, to the best of our knowledge, the first study which showed that the significant anti-invasive effect of a tolerable dose of metformin in KLE cells was completely reversed to the state of no treatment by the addition of MPA; these findings might be mediated through MMP-9 and TGF-β1.